Learner Assessment: Enduring Activity
"Untangling women’s metabolic health: Everything from GLP-1s and hormone therapy to PMOS and hair"

Privacy Collection Statement

The purpose of this statement is to advise you that we may collect, use and disclose various personal information about you, for the purposes of providing services to you, facilitating our internal business operations, including the fullfilment of any legal and regulatory requirements and providing you with information about us and the services that we offer. More detailed information about the way we use, disclose and secure your personal information, and how you can access that information, can be found in our privacy policy, available on the Dietitian Connection website or by contacting us using our details shown on the website.

Thank you for watching the webinar.

This learner assessment follows the latest requirements from the Commission on Dietetic Registration to assess the extent of learners’ understanding/comprehension of the educational content.

Question Title

1. Please enter your name (Required.)

Question Title

2. Please enter your email address (Required.)

Question Title

3. When PMOS symptoms become less prominent in midlife, it means the endocrine and metabolic condition has resolved. (Required.)

True

False

Question Title

4. Which metabolic concerns should stay on a dietitian's radar for a patient in midlife with a history of PMOS? (Select all that apply) (Required.)

Insulin resistance

Dyslipidemia

Central adiposity

Blood pressure

Question Title

5. Insulin resistance, central adiposity, and atherogenic lipid patterns only occur in women with PMOS who are in larger bodies. (Required.)

True

False

Question Title

6. What do the 2023 international evidence-based guidelines conclude about dietary composition for PMOS? (Required.)

Low-carbohydrate patterns are better for PMOS symptoms like insulin resistance

Low-fat, high-fiber patterns are better for PMOS symptoms like hair loss

No single dietary composition is superior; sustainable, individualized patterns are recommended

Intermittent fasting can be a first-line intervention for PMOS symptoms

Question Title

7. Which of the following are recommended nutrition priorities for women in midlife using GLP-1 medications? (Select all that apply) (Required.)

Prioritize protein, resistance exercise, nutrition that supports bone health

Adjust meal size, timing, fluids, and fiber to GI symptoms

Monitor strength, function, metabolic markers, and eating behavior

Move to a low-carbohydrate pattern if insulin resistance is present

Question Title

8. Semaglutide showed 16% vs 12% and tirzepatide 19.2% vs 14.0% total body-weight loss in MHT users vs non-users. What is the appropriate clinical takeaway? (Required.)

MHT should be initiated to enhance GLP-1 response

These are observational associations and are not a reason to initiate MHT to enhance GLP-1 response

MHT should be discontinued before starting a GLP-1

The data establishes that MHT causes greater weight loss

Question Title

9. Which of the following are NFPE hair and scalp findings that may signal an underlying metabolic condition or nutrient deficiency, covered in the presentation? (Select all that apply) (Required.)

Easily plucked hair

Lack of luster

Middle part thinning

Excessive oiliness

Premature graying

Question Title

10. What does the presentation state about zinc status and hair findings? (Required.)

Serum zinc always drops before functional effects appear

Functional effects may be observed before serum levels drop below normal

Zinc deficiency prolongs the anagen phase

Zinc has no role in keratinocyte proliferation

Zinc status is unaffected by medication use

Question Title

11. High-dose biotin can interfere with laboratory testing, including thyroid and troponin assays. (Required.)

True

False

Question Title

12. When NFPE findings suggest insulin resistance or type 2 diabetes, which labs does the presentation direct the RD toward? (Select all that apply)

HcA1c

Fasting insulin and glucose

Lipid profile

Vitamin D

Serum biotin

Question Title

13. What does hair being a non-essential tissue mean for nutrition interventions?

Hair changes should not prompt nutrition intervention

Interventions should go beyond meeting minimum needs to support optimal nutrient availability

Supplementation should be prioritized over food sources

Protein is the only relevant nutrient

Hair findings matter only once a nutrient deficiency is confirmed

Thank you for completing the learner assessment. Please see below for instructions to access your CPE Certificate.

CPE Certificates
You can access CPE certificates for all Dietitian Connection webinars by logging into your account and clicking on the ‘CPEU/CPD Certificates’ heading located in the top right corner of the teal banner.

For a step-by-step guide, feel free to watch this video.

Looking to share feedback?
Share your thoughts with us in this quick 3-minute survey.

US Dietitians: CDR credentialed practitioners may share information regarding the quality of this CPE activity or any CDR prior approved activity with CDR staff by submitting the CDR CPEU Prior Approval Activity Complaint form on CDR’s website.

Learner Assessment: Enduring Activity"Untangling women’s metabolic health: Everything from GLP-1s and hormone therapy to PMOS and hair​"

Question Title

* 1. Please enter your name (Required.)

Question Title

* 2. Please enter your email address (Required.)

Question Title

* 3. When PMOS symptoms become less prominent in midlife, it means the endocrine and metabolic condition has resolved. (Required.)

Question Title

* 4. Which metabolic concerns should stay on a dietitian's radar for a patient in midlife with a history of PMOS? (Select all that apply) (Required.)

Question Title

* 5. Insulin resistance, central adiposity, and atherogenic lipid patterns only occur in women with PMOS who are in larger bodies. (Required.)

Question Title

* 6. What do the 2023 international evidence-based guidelines conclude about dietary composition for PMOS? (Required.)

Question Title

* 7. Which of the following are recommended nutrition priorities for women in midlife using GLP-1 medications? (Select all that apply) (Required.)

Question Title

* 8. Semaglutide showed 16% vs 12% and tirzepatide 19.2% vs 14.0% total body-weight loss in MHT users vs non-users. What is the appropriate clinical takeaway? (Required.)

Question Title

* 9. Which of the following are NFPE hair and scalp findings that may signal an underlying metabolic condition or nutrient deficiency, covered in the presentation? (Select all that apply) (Required.)

Question Title

* 10. What does the presentation state about zinc status and hair findings? (Required.)

Question Title

* 11. High-dose biotin can interfere with laboratory testing, including thyroid and troponin assays. (Required.)

Question Title

* 12. When NFPE findings suggest insulin resistance or type 2 diabetes, which labs does the presentation direct the RD toward? (Select all that apply)

Question Title

* 13. What does hair being a non-essential tissue mean for nutrition interventions?

Learner Assessment: Enduring Activity
"Untangling women’s metabolic health: Everything from GLP-1s and hormone therapy to PMOS and hair"

1. Please enter your name (Required.)

2. Please enter your email address (Required.)

3. When PMOS symptoms become less prominent in midlife, it means the endocrine and metabolic condition has resolved. (Required.)

4. Which metabolic concerns should stay on a dietitian's radar for a patient in midlife with a history of PMOS? (Select all that apply) (Required.)

5. Insulin resistance, central adiposity, and atherogenic lipid patterns only occur in women with PMOS who are in larger bodies. (Required.)

6. What do the 2023 international evidence-based guidelines conclude about dietary composition for PMOS? (Required.)

7. Which of the following are recommended nutrition priorities for women in midlife using GLP-1 medications? (Select all that apply) (Required.)

8. Semaglutide showed 16% vs 12% and tirzepatide 19.2% vs 14.0% total body-weight loss in MHT users vs non-users. What is the appropriate clinical takeaway? (Required.)

9. Which of the following are NFPE hair and scalp findings that may signal an underlying metabolic condition or nutrient deficiency, covered in the presentation? (Select all that apply) (Required.)

10. What does the presentation state about zinc status and hair findings? (Required.)

11. High-dose biotin can interfere with laboratory testing, including thyroid and troponin assays. (Required.)

12. When NFPE findings suggest insulin resistance or type 2 diabetes, which labs does the presentation direct the RD toward? (Select all that apply)

13. What does hair being a non-essential tissue mean for nutrition interventions?